United Kingdom

People: Abeona Therapeutics Inc (ABEO.OQ)

ABEO.OQ on NASDAQ Stock Exchange Capital Market

9:00pm BST
Change (% chg)

$0.02 (+0.67%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Rouhandeh, Steven 

Mr. Steven H. Rouhandeh is an Executive Chairman of the Board Access Pharmaceuticals Inc. Mr. Rouhandeh became our Executive Chairman, Principal Executive Officer, on January 1, 2015. Mr. Rouhandeh has been a director and Chairman of the Board since March 4, 2008. He has been Chief Investment Officer of SCO Capital Partners, a group of New York based life sciences funds since 1997. Mr. Rouhandeh possesses a diverse background in financial services that includes experience in asset management, corporate finance, investment banking and law. He has been active throughout recent years as an executive in venture capital and as a founder of several companies in the biotech field. His experience also includes positions as Managing Director of a private equity group at Metzler Bank, a private European investment firm and Vice President, Investment Banking at Deutsche Bank. Mr. Rouhandeh was also a corporate attorney at New York City-based Cravath, Swaine & Moore. Mr. Rouhandeh holds a J.D. from Harvard Law School, Harvard University and a B.A. Political Science, from Southern Illinois University. Mr. Rouhandeh’s qualifications to serve our Board include his institutional knowledge of our Company and his extensive domestic and international financial experience in the healthcare industry.

Basic Compensation

Total Annual Compensation, USD 540,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,521,000
Fiscal Year Total, USD 2,061,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --